Gene: ERBB2 ×
Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs28933370
rs28933370
ERBB2 ; MIR4728
0.700 GeneticVariation UNIPROT NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer. 23188549

2013
dbSNP: rs28933370
rs28933370
ERBB2 ; MIR4728
0.700 GeneticVariation UNIPROT Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement. 22964825

2012
dbSNP: rs28933370
rs28933370
ERBB2 ; MIR4728
0.700 GeneticVariation UNIPROT National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. 19042984

2008
dbSNP: rs28933370
rs28933370
ERBB2 ; MIR4728
0.700 GeneticVariation UNIPROT Patterns of somatic mutation in human cancer genomes. 17344846

2007
dbSNP: rs28933370
rs28933370
ERBB2 ; MIR4728
0.700 GeneticVariation UNIPROT Lung cancer: intragenic ERBB2 kinase mutations in tumours. 15457249

2004
dbSNP: rs1136201
rs1136201
ERBB2
0.020 GeneticVariation BEFREE Furthermore, no significant association between allelic, dominant, codominant and recessive models of HER2 rs1801200 (V655I) and ovarian cancer was found (<i>p</i> > 0.05). 29535531

2018
dbSNP: rs1136201
rs1136201
ERBB2
0.020 GeneticVariation BEFREE The role of the human epidermal growth factor receptor 2 (HER2) codon 655 (Ile655Val) polymorphism in ovarian cancer is not fully understood. 26666819

2016
dbSNP: rs1801200
rs1801200
ERBB2
0.010 GeneticVariation BEFREE Furthermore, no significant association between allelic, dominant, codominant and recessive models of HER2 rs1801200 (V655I) and ovarian cancer was found (<i>p</i> > 0.05). 29535531

2018